State of Innovation in Marine-Derived Bio-Based Materials for Biomedical and Pharmaceutical Applications
A special issue of Marine Drugs (ISSN 1660-3397). This special issue belongs to the section "Biomaterials of Marine Origin".
Deadline for manuscript submissions: closed (31 October 2023) | Viewed by 15389
Special Issue Editor
Interests: fisheries and aquaculture waste-stream valorization; sustainable bioprocessing; bioactive and functional bioproducts
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
Marine-derived biomaterials have found usage in a wide spectrum of biomedical and pharmaceutical applications due to their bioactivity, biocompatibility and nontoxicity. Since their emergence a few decades ago, marine-derived bio-based materials gained popularity among biomedical researchers and are still a hot topic in biomedicine and pharmaceutical sciences. The aim of the current Special Issue is to highlight recent and innovative developments in marine-derived biomaterials in terms of extraction and processing methods, chemical and biological characterization, as well as their applications in the biomedical and pharmaceutical fields.
In this Special Issue, original research articles and comprehensive reviews are welcome. Research topics may include, but are not limited to, marine proteins (collagen and gelatin), marine polysaccharides (agar, alginates, carrageenans, cellulose, chitin, chitosan, fucoidans, glycosaminoglycans (chondroitin sulfate and hyaluronic acid) and ulvans), and hydroxyapatite obtained from marine organisms.
Dr. Zied Khiari
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Marine Drugs is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- fish, shellfish, and crustaceans
- macroalgae/seaweed
- biomaterials
- proteins
- polysaccharides
- hydroxyapatite
- tissue engineering
- regenerative medicine
- pharmaceutical
- drug delivery
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue polices can be found here.